江 苏 国 信 股 份 有 限 公 司 2025 年 第 三 次 临 时 股 东 会 的 法 律 意 见 书 dentons.cn 北 京 大 成 （ 南 京 ） 律 师 事 务 所 关 于 南京市鼓楼区集慧路 18 号联创大厦 A 座 7-11 层（210036） 18 Jihui Road, 7-11/F of Building A, Lianchuang Mansion, Gulou District,Nanjing,China,210036 Tel: +86-25-8375 5101 Fax: +86-25-8375 5005 dentons.cn 北京大成（南京）律师事务所 关于江苏国信股份有限公司 2025 年第三次临时股东会的法律意见书 致：江苏国信股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国公司 法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市公司股东会规则》（以 下简称"《股东会规则》"）等法律、法规和其他有关规范性文件的要求，北京大成（南 京）律师事务所（以下简称"本所"）接受江苏国信股份有限公司（以下简称"公司"）的 委托，指派律师参 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 江苏国信股份有限公司（以下简称"公司"）第七届董事会第一 次会议通知于 2025 年 12 月 8 日，以书面、通讯方式发给公司董事， 会议于 2025 年 12 月 18 日在公司会议室以现场方式召开。本次会议 应出席董事七名，实际出席董事七名。本次会议的召开符合《公司法》 和《公司章程》的规定。经与会董事推选，本次会议由徐文进先生召 集并主持。与会董事经过认真审议，做出如下决议： 一、审议通过《关于选举公司第七届董事会董事长的议案》 选举徐文进先生为江苏国信股份有限公司第七届董事会董事长， 任期三年（自本次董事会会议审议通过之日起至本届董事会届满止）。 徐文进先生现任控股股东江苏省国信集团有限公司总经理，兼任我公 司董事长。 表决结果：7 票赞成，0 票反对，0 票弃权。 二、审议通过《关于选举公司第七届董事会专门委员会委员的议 案》 证券代码：002608 证券简称：江苏国信 公告编号：2025-052 江苏国信股份有限公司 第七届董事会第一次会议决议公告 1 为完善公司法人治理结构，公司设立第七届董事会专 ...

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

股票频道更多独家策划、专家专栏，免费查阅>> 责任编辑：山上 格隆汇12月12日丨江苏国信(002608.SZ)公布，公司控股子公司江苏国信马洲发电有限公司（以下简 称"国信马洲"）新建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于 2025年12月12日正式投产运营。 此次投产的国信马洲100万千瓦机组选用先进的二次再热、超超临界技术，机组能源利用率高，各排放 指标实现超低排放；创新融合煤电机组熔盐储能系统，可高效灵活响应新型电力系统的调节需求。该机 组投产后将填补江苏省"十五五"期间电力供应缺口，进一步优化区域电力结构。 ...

江苏国信（002608）(002608.SZ)公告，公司控股子公司江苏国信马洲发电有限公司(简称"国信马洲")新 建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于2025年12月12日正 式投产运营。 ...

智通财经APP讯，江苏国信(002608.SZ)公告，公司控股子公司江苏国信马洲发电有限公司(简称"国信马 洲")新建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于2025年12月 12日正式投产运营。 ...

每经AI快讯，12月12日，江苏国信(002608.SZ)公告称，公司控股子公司江苏国信马洲发电有限公司新 建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于2025年12月12日正 式投产运营。该机组能源利用率高，各排放指标实现超低排放，并创新融合煤电机组熔盐储能系统，可 高效灵活响应新型电力系统的调节需求。该机组投产后将填补江苏省"十五五"期间电力供应缺口，进一 步优化区域电力结构。 ...

转自：证券时报 人民财讯12月12日电，江苏国信(002608)12月12日公告，公司控股子公司江苏国信马洲发电有限公司新 建的一台1000MW二次再热超超临界燃煤发电机组，完成168小时满负荷试运行，于12月12日正式投产 运营。 ...

证券代码：002608 证券简称：江苏国信 公告编号：2025-050 特此公告。 江苏国信股份有限公司董事会 2025 年 12 月 13 日 1 的自愿性信息披露公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 江苏国信股份有限公司（以下简称"公司"）控股子公司江苏国信马 洲发电有限公司（以下简称"国信马洲"）新建的一台 1000MW 二次 再热超超临界燃煤发电机组，完成 168 小时满负荷试运行，于 2025 年 12 月 12 日正式投产运营。 此次投产的国信马洲 100 万千瓦机组选用先进的二次再热、超超临 界技术，机组能源利用率高，各排放指标实现超低排放；创新融合煤电 机组熔盐储能系统，可高效灵活响应新型电力系统的调节需求。该机组 投产后将填补江苏省"十五五"期间电力供应缺口，进一步优化区域电 力结构。 江苏国信股份有限公司 关于子公司国信马洲 100 万千瓦机组投产 ...